Related references
Note: Only part of the references are listed.A guide to economic evaluation: Methods for cost-effectiveness analysis of person-level data
Jeffrey S. Hoch et al.
JOURNAL OF TRAUMATIC STRESS (2006)
Analyses of cost data in economic evaluations conducted alongside randomized controlled trials
Jalpa A. Doshi et al.
VALUE IN HEALTH (2006)
Good research practices for cost-effectiveness analysis alongside clinical trials: The ISPOR RCT-CEA task force report
S Ramsey et al.
VALUE IN HEALTH (2005)
An Introduction to Economic Evaluation: What's in a Name?
Jeffrey S. Hoch et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2005)
Treatment costs or youths receiving multisystemic therapy for hospitalization after a psychiatric crisis
AJ Sheidow et al.
PSYCHIATRIC SERVICES (2004)
Incremental and average cost-effectiveness ratios: Will physicians make a distinction?
JC Hershey et al.
RISK ANALYSIS (2003)
Conversion from intravenous to intramuscular hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long-term prophylaxis to prevent hepatitis B recurrence after liver transplantation
SH Han et al.
LIVER TRANSPLANTATION (2003)
Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis
JS Hoch et al.
HEALTH ECONOMICS (2002)
An economic comparison of chloroquine and sulfadoxine-pyrimethamine as first-line treatment for malaria in South Africa: development of a model for estimating recurrent direct costs
JJ Wilkins et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2002)
A comparison of effectiveness and cost between two models of care for individuals with schizophrenia living in Taiwan
ECL Lin et al.
ARCHIVES OF PSYCHIATRIC NURSING (2001)
Representing uncertainty: The role of cost-effectiveness acceptability curves
E Fenwick et al.
HEALTH ECONOMICS (2001)
An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy
SHB Han et al.
LIVER TRANSPLANTATION (2000)
The quality of reporting in published cost-utility analyses, 1976-1997
PJ Neumann et al.
ANNALS OF INTERNAL MEDICINE (2000)
Share Paper
